National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
71.33
+1.38 (1.97%)
Jul 29, 2025, 4:00 PM - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
The 5 analysts that cover National Health Investors stock have a consensus rating of "Buy" and an average price target of $84.6, which forecasts a 18.6% increase in the stock price over the next year. The lowest target is $77 and the highest is $92.
Price Target: $84.6 (+18.6%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 2 | 2 | 2 | 1 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 5 | 5 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Hold → Buy Upgrades $80 | Hold → Buy | Upgrades | $80 | +12.15% | Jul 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $76 → $77 | Hold | Maintains | $76 → $77 | +7.95% | Jun 9, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $70 → $76 | Hold | Maintains | $70 → $76 | +6.55% | Mar 19, 2025 |
| Wedbush | Wedbush | Buy Reiterates $88 | Buy | Reiterates | $88 | +23.37% | Mar 17, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | +0.94% | Dec 23, 2024 |
Financial Forecast
Revenue This Year
358.17M
from 335.58M
Increased by 6.73%
Revenue Next Year
401.20M
from 358.17M
Increased by 12.01%
EPS This Year
3.12
from 3.13
Decreased by -0.16%
EPS Next Year
3.35
from 3.12
Increased by 7.18%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 402.7M | 507.8M | 602.1M | ||
| Avg | 358.2M | 401.2M | 441.1M | ||
| Low | 330.8M | 343.8M | 345.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.0% | 41.8% | 50.1% | ||
| Avg | 6.7% | 12.0% | 9.9% | ||
| Low | -1.4% | -4.0% | -13.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.36 | 3.61 | 3.64 |
| Avg | 3.12 | 3.35 | 3.43 |
| Low | 2.97 | 3.17 | 3.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 7.3% | 15.6% | 8.8% |
| Avg | -0.2% | 7.2% | 2.5% |
| Low | -5.1% | 1.3% | -4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.